Picoliter Inc. One of Top-Ten New Companies of 2001

Picoliter Inc. announced today that the company was selected by Drug Discovery Today as one of the top start-up companies of 2001, as voted by six internationally renowned experts involved in the pharmaceutical/biotechnology industry. In a supplement to the March 1, 2002 issue (Drug Discovery Today, 2002, 7:5:S1-S2), Picoliter and nine other early-to-middle stage companies were profiled and their business strategies were discussed.

March 01, 2002
Mountain View, CA
Mountain View, CA, March 1, 2002—Picoliter Inc. announced today that the company was selected by Drug Discovery Today as one of the top start-up companies of 2001, as voted by six internationally renowned experts involved in the pharmaceutical/biotechnology industry. In a supplement to the March 1, 2002 issue (Drug Discovery Today, 2002, 7:5:S1-S2), Picoliter and nine other early-to-middle stage companies were profiled and their business strategies were discussed.

“We are pleased to be recognized by such a well-respected publication as Drug Discovery Today,” commented Dr. Elaine J. Heron, CEO of Picoliter.  “This article is an excellent introduction to the many applications of our small-volume liquid transfer technology to drug discovery and related applications.”

About Picoliter Inc.
Picoliter Inc. is a development stage company located in Mountain View, CA.  The company has developed a novel technology for moving and analyzing small amounts of liquid using ultrasound energy.  The PicoliterTM liquid handling technology has broad applications in the life science tools market including microarrays, dispensing equipment, and living cell transfer devices.

Members of the Picoliter management team have successfully brought a wide variety of products based on new technologies to market.  The company includes individuals with experience in senior management, manufacturing, business development, intellectual property protection and product development at Affymetrix, Applied Biosystems, Eastman Kodak, International Paper, Molecular Dynamics, Symyx, and Xerox PARC.

About Drug Discovery Today
Drug Discovery Today was launched in 1996 by Elsevier Science London as part of the Trends family of journals.  Since then, Drug Discovery Today has flourished to become a leader in its field: the quality of the editorial content means that it is highly regarded by drug discovery professionals and is seen as an essential source of information.  Drug Discovery Today is the most highly cited journal in drug discovery and is peer-reviewed for authoritative coverage.